divendres, 22 de maig del 2015

EuroPCR 2015: Edwards pauses Fortis TMVI, TAVI gains across the board

Replacement heart valves once again take center stage at the annual EuroPCR conference in Paris this week, as Edwards Lifesciences pauses its Fortis trial and positive new data comes in on the next generation of aortic implants.

EuroPCR 2015: Edwards pauses Fortis TMVI, TAVI gains across the board

read more



from MassDevice - FDA and Medical device business news and jobs for the medical device industry http://ift.tt/1c9MTWU

Cap comentari:

Publica un comentari a l'entrada